A Study of Disease Progression and Anti-HIV Treatments

NCT00001068 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

210

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lamivudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)